spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry News:  Fuse 

Devices Orthopaedic Neurosurgery

 News Release - May 16, 2012

Medtronic Receives Notification That U.S. Department of Justice and U.S. Attorney’s Office Have Closed Their Investigation of Activities Relating to INFUSE(R) Bone Graft

Closure Ends Federal Civil and Criminal Investigations of the Company

MINNEAPOLIS--(Healthcare Sales & Marketing Network)--Medtronic, Inc. (NYSE: MDT ) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the District of Massachusetts that federal prosecutors have closed their investigation of Medtronic related to INFuse® Bone Graft. The status of this federal civil and criminal investigation has been regularly reported in Medtronic’s quarterly disclosures.

“After several years of investigation, we are pleased that the Department of Justice and the U.S. Attorney’s Office have come to the decision to close their investigation of the company related to INFuse Bone Graft,” said Chris O’Connell, executive vice president and group president, Restorative Therapies Group, which includes the company’s Spinal business.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Medtronic may be subject to legal actions regarding the INFuse Bone Graft or its other products in addition to those described herein. The outcomes of such legal actions, and the impact of such legal actions on Medtronic’s financial condition and results of operation, are not within Medtronic’s control.

Source: Medtronic

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

Search: Medtronic 
Search: INFUSE Bone Graft 
Search: Bone Graft 

 Related News Items

Medtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens

Medtronic Announces CE Mark for Stealth AXiS(TM) Surgical System

Medtronic Completes Acquisition of CathWorks, Expanding its Leadership in Transforming Care for Patients with Cardiovascular Disease

Healthcare Industry NewsFeed  


FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!